Background Parenchymal Signal Enhancement Ratio at Preoperative MR Imaging: Association with Subsequent Local Recurrence in Patients with Ductal Carcinoma in Situ after Breast Conservation Surgery

被引:53
作者
Kim, Sun-Ah [1 ]
Cho, Nariya [1 ]
Ryu, Eun Bi [1 ]
Seo, Mirinae [1 ]
Bae, Min Sun [1 ]
Chang, Jung Min [1 ]
Moon, Woo Kyung [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
关键词
CANCER; RISK; RADIOTHERAPY; CHEMOTHERAPY; PARAMETERS; DENSITY; SCIENCE; DISEASE; MODEL; STATE;
D O I
10.1148/radiol.13130459
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To retrospectively investigate whether the background parenchymal features around a tumor at preoperative dynamic contrast material-enhanced magnetic resonance (MR) imaging are associated with ipsilateral breast tumor recurrence (IBTR)-free survival in patients with ductal carcinoma in situ (DCIS) after breast conservation surgery. Materials and Methods: The institutional review board approved this study, and the requirement for informed consent was waived. Between 2004 and 2009, 215 consecutive women with pure DCIS who had undergone preoperative dynamic contrast-enhanced MR imaging and curative breast conservation surgery were identified. Clinical-pathologic features (age, menopausal status, presentation of clinical findings, biopsy method, tumor size, nuclear grade, hormonal receptor status, margin status, and adjuvant therapy) and MR imaging features (lesion size, background parenchymal enhancement grade, fibroglandular density, parenchymal signal enhancement ratio [SER] around the tumor, lesion type, and lesion kinetics) were analyzed. A Cox proportional hazards model was used to determine the association between MR imaging variables and IBTR-free survival after controlling for clinical-pathologic variables. Reproducibility of SER measurements was evaluated by using the intraclass correlation coefficient. Results: There were 15 of 215 (7.0%) IBTR cases (nine DCIS cases and six invasive cases) at a median of 36 months (range, 11-61 months). Multivariate analysis showed that higher parenchymal SER (hazard ratio [HR] = 2.028, P < .001 for reader 1; HR = 1.652, P,.001 for reader 2) and larger histologic tumor size (HR = 1.360, P <.009 for reader 1; HR = 1.402, P < .006 for reader 2) were independent factors associated with worse IBTR-free survival. The intraclass correlation coefficient of SER measurements between two readers was 0.852 (95% confidence interval: 0.811, 0.885). Conclusion: Higher parenchymal SER around the tumor at preoperative dynamic contrast-enhanced MR imaging and larger histologic tumor size were independent factors associated with worse IBTR-free survival in patients with DCIS after breast conservation surgery. (c) RSNA, 2013
引用
收藏
页码:699 / 707
页数:9
相关论文
共 26 条
[1]   National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009 [J].
Allegra, Carmen J. ;
Aberle, Denise R. ;
Ganschow, Pamela ;
Hahn, Stephen M. ;
Lee, Clara N. ;
Millon-Underwood, Sandra ;
Pike, Malcolm C. ;
Reed, Susan D. ;
Saftlas, Audrey F. ;
Scarvalone, Susan A. ;
Schwartz, Arnold M. ;
Slomski, Carol ;
Yothers, Greg ;
Zon, Robin .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03) :161-169
[2]  
[Anonymous], 2003, BREAST IM REP DAT SY
[3]   Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-Year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J].
Bijker, Nina ;
Meijnen, Philip ;
Peterse, Johannes L. ;
Bogaerts, Jan ;
Van Hoorebeeck, Irene ;
Julien, Jean-Pierre ;
Gennaro, Massimiliano ;
Rouanet, Philippe ;
Avril, Antoine ;
Fentiman, Ian S. ;
Bartelink, Harry ;
Rutgers, Emiel J. Th. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3381-3387
[4]   Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer [J].
Cichon, Magdalena A. ;
Degnim, Amy C. ;
Visscher, Daniel W. ;
Radisky, Derek C. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2010, 15 (04) :389-397
[5]   Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice [J].
Dolan, M ;
Snover, D .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) :766-770
[6]   Cancer Invasion and the Microenvironment: Plasticity and Reciprocity [J].
Friedl, Peter ;
Alexander, Stephanie .
CELL, 2011, 147 (05) :992-1009
[7]   Mammographic density and breast cancer after ductal carcinoma in situ [J].
Habel, LA ;
Dignam, JJ ;
Land, SR ;
Salane, M ;
Capra, AM ;
Julian, TB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (19) :1467-1472
[8]   Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy [J].
Hattangadi, Jona ;
Park, Catherine ;
Rembert, James ;
Klifa, Catherine ;
Hwang, Jimmy ;
Gibbs, Jessica ;
Hylton, Nola .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (06) :1630-1636
[9]   Mammary field cancerization: molecular evidence and clinical importance [J].
Heaphy, Christopher M. ;
Griffith, Jeffrey K. ;
Bisoffi, Marco .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) :229-239
[10]   Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast [J].
Holmberg, Lars ;
Garmo, Hans ;
Granstrand, Bengt ;
Ringberg, Anita ;
Arnesson, Lars-Gunnar ;
Sandelin, Kerstin ;
Karlsson, Per ;
Anderson, Harald ;
Emdin, Stefan .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1247-1252